Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 17 MRK Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness
May 17 VKTX 4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
May 17 MRK 5 Stocks Powering the Dow ETF Year to Date
May 17 TNDM Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?
May 16 VKTX Viking falls after Roche’s obesity drug data; RayJay upgrades (update)
May 16 RZLT Rezolute reports Q3 results
May 16 MRK Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16 MRK Merck (MRK) Crossed Above the 20-Day Moving Average: What That Means for Investors
May 16 GCTK GLUCOTRACK’S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY
May 16 MRK The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
May 16 MRK Merck & Co., Inc. (MRK) BofA Securities 2024 Health Care Conference (Transcript)
May 15 VKTX Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today
May 15 GCTK Glucotrack announces 1-for-5 reverse stock split
May 15 GCTK GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT
May 15 RZLT Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
May 15 MRK Top Stock Reports for Broadcom, Merck & Airbnb
May 15 VKTX Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
May 15 MRK Merck to Present New Data at 2024 ASCO Annual Meeting Demonstrating Advancements in Novel Oncology Treatment Approaches Across Broad Portfolio and Diverse Pipeline
May 15 BLTE Belite Bio, Inc 2024 Q1 - Results - Earnings Call Presentation
May 15 BLTE Belite Bio, Inc (BLTE) Q1 2024 Earnings Call Transcript
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags